NCT06506487

Brief Summary

This study is a two-phase explanatory sequential mixed-methods study in Chinese residential dementia care. Phase I is a pragmatic 1:1 exploratory pilot cluster randomized trial in six nursing homes in Zhengzhou, China, comparing staff-mediated doll therapy plus routine nursing care with routine nursing care alone among 142 residents with dementia assessed at baseline, 6 weeks, and 12 weeks. Registered primary outcomes are class-specific daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants. Secondary and contextual outcomes include behavioral and psychological symptoms of dementia, activities of daily living, cognitive enhancer use, traditional Chinese medicine use, and doll engagement/adherence. Phase II uses semi-structured interviews with staff and family caregivers to explore acceptability, implementation, training needs, cultural fit, and ethical considerations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

July 31, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

1.4 years

First QC Date

July 11, 2024

Last Update Submit

July 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Class-Specific Daily Medication Dose

    This primary outcome assesses class-specific mean daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants over 12 weeks. Antipsychotics are expressed as chlorpromazine-equivalent daily dose, anxiolytics as diazepam-equivalent daily dose, and antidepressants using the WHO defined daily dose framework. Changes are compared between doll therapy plus routine nursing care and routine care alone.

    12 weeks

Secondary Outcomes (2)

  • Change in Behavioral and Psychological Symptoms of Dementia (BPSD)

    12 weeks

  • Change in Activities of Daily Living (ADL)

    12 weeks

Other Outcomes (3)

  • Change in Cognitive Enhancer Use

    12 weeks

  • Change in Traditional Chinese Medicine Use

    12 weeks

  • Doll Engagement and Adherence

    12 weeks

Study Arms (2)

Staff-Mediated Doll Therapy plus Routine Nursing Care

EXPERIMENTAL

Residents in intervention homes received routine nursing care plus a staff-mediated doll-therapy care package. The package included staff training, a structured doll-therapy introduction with eight planned sessions over approximately 15 days, continued access to a personal doll during routine care, structured interaction and relational engagement, and ongoing monitoring of resident assent, dissent, distress, and fit.

Behavioral: Doll Therapy

Routine Nursing Care

NO INTERVENTION

Residents in control homes received routine nursing care alone. Control homes did not receive study-provided dolls or structured doll-therapy training during the study period.

Interventions

Doll TherapyBEHAVIORAL

Staff-mediated doll therapy is a person-centered, attachment-informed non-pharmacological care package in which trained nursing-home staff introduce a lifelike doll respectfully, support resident-led interaction, monitor assent and dissent, and provide continued access to a personal doll during routine care. The intervention included eight planned introductory sessions over approximately 15 days, structured interaction, relational engagement, and implementation within ordinary nursing-home care.

Staff-Mediated Doll Therapy plus Routine Nursing Care

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 65 years or older.
  • Nursing home resident with a documented clinical diagnosis of dementia recorded in the medical or nursing-home record by a qualified physician using DSM-5, ICD-10, ICD-11, or current Chinese clinical guidelines for dementia and cognitive impairment; where the underlying diagnostic criteria were not specified in the record, the site clinician reconfirmed the diagnosis against DSM-5 criteria before enrollment.
  • Adequate visual capacity to recognize a doll at screening.
  • Sufficient upper-limb function to hold or caress the doll safely.
  • Availability of a legally authorized representative able to provide written informed consent.
  • Resident assent whenever appropriate.

You may not qualify if:

  • Acute medical instability.
  • Severe sensory or physical limitations preventing safe participation.
  • Severe communication impairment precluding meaningful participation.
  • Major psychiatric disorders unrelated to dementia.
  • Resident dissent or refusal when assent was appropriate, or safety concerns that made doll interaction unsuitable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sias University

Zhengzhou, Henan, 451100, China

Location

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Zhenti Cui

    Social and Preventive Medicine, Malaya University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The intervention was visible in routine care, so residents, direct caregivers, and intervention deliverers were not blinded. Medication outcomes were extracted from medication records by assessors masked to allocation where feasible; caregiver-reported NPI-12 and Barthel ratings could not be fully blinded.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Pragmatic, parallel-group, 1:1 cluster randomized pilot trial in six nursing homes. The nursing home was the unit of randomization to reduce contamination; three homes were assigned to staff-mediated doll therapy plus routine nursing care and three to routine nursing care alone.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 17, 2024

Study Start

July 31, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

July 13, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified quantitative analysis-ready data underlying the reported results and analytic code may be shared with qualified researchers on reasonable request. Because the dataset contains potentially identifiable nursing-home clinical information, data will not be posted publicly. The qualitative coding framework may also be available on reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
3 months to 5 years following article publication
Access Criteria
Researchers must provide a methodologically sound proposal and obtain appropriate ethics and institutional approvals where required. Access will be subject to review by the study team and the responsible institution, and requestors must sign a data access agreement covering confidentiality, permitted use, and secure storage.

Locations